Synergy in Action

14th Annual Scientific Meeting

20 – 22 February, 2018   //   The Fairmont, Washington DC


Tuesday 20 February 2018




Unresolved Problems in Neuroscience Drug Development
Point/Counterpoint (A Kalali)
1) Amyloid hypothesis and Alzheimer’s drug development – A Butler
2) Does increasing the sample size provide greater precision for detecting treatment effects?  – G Sachs
3) Should adaptive designs be allowed for pivotal trials? – J Kent
4:25-6:00 Working Group Sessions
6:00-7:00 Welcome Reception
Wednesday 21 February 2018
8:15 Use of FDA Schizophrenia NDA Database as an Exemplar to Improve RCT Efficiency; Can the Model Be Extended? (T Farchione/H Martynowicz)
Noon-2:00 Annual Business Meeting/Luncheon
2:10 Methodological Challenges Related to Rare and Orphan Disease Drug Development (J Busner, J Dunn, R Anand)
6:00-8:00 Poster Session/Reception
Submission Form and Guidelines
Thursday 22 February 2018
8:15 Innovative Approaches for Slowing Disease Progression in Parkinson’s Disease (K Budur, I Shoulson, I Turkoz, M Frasier)
(in collaboration with the Michael J Fox Foundation)
Mid-Afternoon Meeting Adjourns